ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1996;61:1617
© 1996 The Society of Thoracic Surgeons

Discussion

Discussion

The first 20% of the full text of this article appears below.

See also page 1609.

DR DANIEL L. MILLER (Louisville, KY): This was an excellent presentation and a great deal of work. First of all, could you explain the selection criteria for the 20 patients who received TNF? Also, have you considered first doing a cytoreductive operation to remove as many of the metastases as possible before giving TNF? If you have, what were the results?

DR PASS: As you know, we do a lot of metastasectomies at the . . . [Full Text of this Article]


Related Article

Isolated Lung Perfusion With Tumor Necrosis Factor for Pulmonary Metastases
Harvey I. Pass, Daphne J. Y. Mew, Karen C. Kranda, Barbara K. Temeck, Jessica S. Donington, and Steven A. Rosenberg
Ann. Thorac. Surg. 1996 61: 1609-1617. [Abstract] [Full Text]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The Society of Thoracic Surgeons.